PT4107252T - Método de produção de aav - Google Patents

Método de produção de aav

Info

Publication number
PT4107252T
PT4107252T PT218113850T PT21811385T PT4107252T PT 4107252 T PT4107252 T PT 4107252T PT 218113850 T PT218113850 T PT 218113850T PT 21811385 T PT21811385 T PT 21811385T PT 4107252 T PT4107252 T PT 4107252T
Authority
PT
Portugal
Prior art keywords
aav
production
Prior art date
Application number
PT218113850T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Cevec Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cevec Pharmaceuticals Gmbh filed Critical Cevec Pharmaceuticals Gmbh
Publication of PT4107252T publication Critical patent/PT4107252T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10Perfusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material
    • C12N2750/14152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PT218113850T 2020-11-25 2021-11-23 Método de produção de aav PT4107252T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20209811.7A EP4006141A1 (en) 2020-11-25 2020-11-25 Method for the production of aav

Publications (1)

Publication Number Publication Date
PT4107252T true PT4107252T (pt) 2025-03-14

Family

ID=73597941

Family Applications (1)

Application Number Title Priority Date Filing Date
PT218113850T PT4107252T (pt) 2020-11-25 2021-11-23 Método de produção de aav

Country Status (15)

Country Link
US (1) US20240263148A1 (enExample)
EP (3) EP4006141A1 (enExample)
JP (2) JP7601339B2 (enExample)
KR (1) KR102700433B1 (enExample)
CN (1) CN116209748A (enExample)
AU (1) AU2021388811B2 (enExample)
CA (1) CA3174017C (enExample)
DK (1) DK4107252T3 (enExample)
ES (1) ES3017247T3 (enExample)
FI (1) FI4107252T3 (enExample)
IL (1) IL296770B2 (enExample)
MX (1) MX2022013385A (enExample)
PT (1) PT4107252T (enExample)
WO (1) WO2022112218A1 (enExample)
ZA (1) ZA202210745B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202323529A (zh) * 2021-10-18 2023-06-16 美商再生元醫藥公司 包括腺病毒相關病毒聚核苷酸的真核細胞
TW202342740A (zh) * 2022-03-07 2023-11-01 美商奧崔基尼克斯製藥公司 改良的批量aav生產系統和方法
JP2025519228A (ja) * 2022-06-03 2025-06-24 エフ. ホフマン-ラ ロシュ アーゲー 組換えaav粒子を生成するための方法
WO2025047766A1 (ja) * 2023-08-29 2025-03-06 富士フイルム株式会社 ウイルスの製造方法および細胞への核酸導入方法
WO2025171001A1 (en) 2024-02-06 2025-08-14 Regeneron Pharmaceuticals, Inc. Compositions and methods for improved production of aav viral vectors
WO2025168663A1 (en) 2024-02-09 2025-08-14 F. Hoffmann-La Roche Ag Method for producing recombinant adeno-associated viral particles
EP4606816A1 (en) 2024-02-26 2025-08-27 Universitat Autónoma De Barcelona (UAB) Method for production of gene therapy vehicles in mammalian cells
WO2025226558A1 (en) 2024-04-22 2025-10-30 Ultragenyx Pharmaceutical Inc. Multi-step filtration and clarification methods for recombinant adeno-associated virus purification
WO2025252480A1 (en) 2024-06-07 2025-12-11 F. Hoffmann-La Roche Ag Method for purifying plasmid dna

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020168342A1 (en) * 1994-11-03 2002-11-14 Cell Genesys, Inc. Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
US6989264B2 (en) * 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
WO2000024916A1 (en) * 1998-10-27 2000-05-04 Crucell Holland B.V. Improved aav vector production
US6844192B2 (en) * 2001-06-29 2005-01-18 Wake Forest University Adenovirus E4 protein variants for virus production
CA3018264A1 (en) * 2016-04-12 2017-10-19 Artemis Biosystems, Inc. Perfusion filtration systems
EP3456822A1 (en) * 2017-09-19 2019-03-20 CEVEC Pharmaceuticals GmbH Inducible aav rep genes
EP3914696A4 (en) * 2019-01-25 2022-12-14 Biogen MA Inc. SEED CULTIVATION METHOD FOR THE PRODUCTION OF AAV
EP3962536A1 (en) * 2019-04-29 2022-03-09 Voyager Therapeutics, Inc. Systems and methods for producing baculoviral infected insect cells (biics) in bioreactors

Also Published As

Publication number Publication date
US20240263148A1 (en) 2024-08-08
ES3017247T3 (en) 2025-05-12
IL296770B2 (en) 2025-10-01
EP4107252A1 (en) 2022-12-28
EP4107252B1 (en) 2025-02-19
CA3174017A1 (en) 2022-06-02
AU2021388811A1 (en) 2022-11-03
AU2021388811B2 (en) 2023-02-23
MX2022013385A (es) 2022-11-30
JP7601339B2 (ja) 2024-12-17
EP4006141A1 (en) 2022-06-01
CA3174017C (en) 2025-05-06
WO2022112218A1 (en) 2022-06-02
CN116209748A (zh) 2023-06-02
JP2024144435A (ja) 2024-10-11
EP4596674A2 (en) 2025-08-06
KR20220164801A (ko) 2022-12-13
FI4107252T3 (fi) 2025-03-26
KR102700433B1 (ko) 2024-08-30
DK4107252T3 (da) 2025-03-17
IL296770A (en) 2022-11-01
ZA202210745B (en) 2023-05-31
IL296770B1 (en) 2025-06-01
JP2023518919A (ja) 2023-05-08
EP4596674A3 (en) 2025-10-22

Similar Documents

Publication Publication Date Title
ZA202210745B (en) Method for the production of aav
IL304740A (en) A new process
PL3765433T3 (pl) Sposób wytwarzania glikolu etylenowego
PL3766570T3 (pl) Sposób wytwarzania alkoksylanów
LT3765432T (lt) Etileno glikolio gamybos būdas
PL3755681T3 (pl) Sposób wytwarzania 4-boronofenyloalaniny
PL3838381T3 (pl) Sposób wytwarzania tiosiarczanu amonu
IL289971A (en) Improved methods for the production of plants
GB201814291D0 (en) Process for the production of gallium radionculides
IL287063A (en) A method for producing a similar structure-biotissue
IL285858A (en) A process for making levoamphetamine
GB202007122D0 (en) New process
GB202007724D0 (en) Novel method
EP3925964A4 (en) METHOD FOR PRODUCTION OF OLIGONUCLEOTIDES
IL316018A (en) IMPROVED PROCESS FOR THE MANUFACTURE OF OSIMERTINIB
HUE067878T2 (hu) Eljárás alkilamidotiazolok gyártásához
PL3489218T3 (pl) Sposób wytwarzania fenyloaminohydroksyantrachinonów
HUP1800125A2 (en) Process for production of iloprost
EP3995479A4 (en) PROCESS FOR MANUFACTURING ALKANE
EP3901361A4 (en) PROCESS FOR PRODUCTION OF RUBBER REINFORCING FIBERS
TWI907338B (zh) 生產硫的方法
EP4052703A4 (en) METHOD FOR SUPPRESSING THE PRODUCTION OF ASENAPINE N-OXIDE
PL3980372T3 (pl) Sposób wytwarzania wodoru
IL286358A (en) A method for the production of alpha-allylated cycloalkanone
HUP1900118A1 (hu) Új eljárás propilén elõállítására